肝硬化心肺并发症的管理
Management of cardiopulmonary complications of cirrhosis.
作者信息
Sawant Prabha, Vashishtha C, Nasa M
机构信息
Department of Gastroenterology, Lokmanya Tilak Municipal Medical College, Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400022, India.
出版信息
Int J Hepatol. 2011;2011:280569. doi: 10.4061/2011/280569. Epub 2011 Jul 19.
Abstract
Advanced portal hypertension accompanying end-stage liver disease results in an altered milieu due to inadequate detoxification of blood from splanchnic circulation by the failing liver. The portosystemic shunts with hepatic dysfunction result in an increased absorption and impaired neutralisation of the gastrointestinal bacteria and endotoxins leads to altered homeostasis with multiorgan dysfunction. The important cardiopulmonary complications are cirrhotic cardiomyopathy, hepatopulmonary syndrome, portopulmonary hypertension, and right-sided hydrothorax.
摘要
晚期肝病伴发的严重门静脉高压会导致内环境改变，原因是肝脏功能衰竭，无法充分清除来自内脏循环的血液中的毒素。肝功能不全导致的门体分流会使胃肠道细菌和内毒素的吸收增加且中和受损，进而导致内环境稳态改变并出现多器官功能障碍。重要的心肺并发症包括肝硬化性心肌病、肝肺综合征、门肺高压和右侧胸腔积液。
相似文献
1
Management of cardiopulmonary complications of cirrhosis.
Int J Hepatol. 2011;2011:280569. doi: 10.4061/2011/280569. Epub 2011 Jul 19.
2
Diagnosis and Management of Cirrhotic Cardiomyopathy.
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):186-199. doi: 10.1016/j.jceh.2021.08.016. Epub 2021 Aug 21.
3
[Pulmonary complications of liver cirrhosis: hepatopulmonary syndrome, portopulmonary hypertension and hepatic hydrothorax].
Internist (Berl). 2010 Mar;51 Suppl 1:255-63. doi: 10.1007/s00108-009-2503-y.
4
Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats.
Clin Sci (Lond). 2021 Dec 22;135(24):2709-2728. doi: 10.1042/CS20210602.
5
Complications of cirrhosis. A 50 years flashback.
Scand J Gastroenterol. 2015 Jun;50(6):763-80. doi: 10.3109/00365521.2015.1021709. Epub 2015 Apr 16.
6
[Pulmonary Complications in Patients with Liver Cirrhosis].
Korean J Gastroenterol. 2023 Nov 25;82(5):213-223. doi: 10.4166/kjg.2023.123.
7
Respiratory dysfunction and pulmonary disease in cirrhosis and other hepatic disorders.
Respir Care. 2007 Aug;52(8):1030-6.
8
Pulmonary Complications of Portal Hypertension.
Clin Liver Dis. 2019 Nov;23(4):683-711. doi: 10.1016/j.cld.2019.06.003. Epub 2019 Aug 9.
9
Pulmonary complications of cirrhosis.
Med Clin North Am. 2009 Jul;93(4):871-83, viii. doi: 10.1016/j.mcna.2009.03.006.
10
Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.
World J Gastroenterol. 2014 Nov 14;20(42):15499-517. doi: 10.3748/wjg.v20.i42.15499.
引用本文的文献
1
Paradoxical Cerebral Embolization during Transjugular Intrahepatic Portosystemic Shunt Creation and Variceal Sclerotherapy.
Semin Intervent Radiol. 2024 Jul 10;41(2):220-225. doi: 10.1055/s-0044-1786539. eCollection 2024 Apr.
2
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management.
World J Gastroenterol. 2023 Dec 14;29(46):6028-6048. doi: 10.3748/wjg.v29.i46.6028.
3
Risk factors for hepatic hydrothorax in patients with cirrhosis: a clinical retrospective study.
Front Med (Lausanne). 2023 Jun 1;10:1165604. doi: 10.3389/fmed.2023.1165604. eCollection 2023.
4
Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China.
BMC Gastroenterol. 2022 Jul 7;22(1):333. doi: 10.1186/s12876-022-02412-9.
5
Systemic vascular resistance and fluid status in patients with decompensated liver cirrhosis with or without functional renal failure in Egypt.
Electron Physician. 2015 Aug 10;7(4):1174-82. doi: 10.14661/2015.1174-1182. eCollection 2015 Aug.
6
Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature.
Medicine (Baltimore). 2014 May;93(3):135-142. doi: 10.1097/MD.0000000000000025.
本文引用的文献
1
Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups.
Am J Transplant. 2008 Nov;8(11):2445-53. doi: 10.1111/j.1600-6143.2008.02384.x. Epub 2008 Sep 8.
2
Screen for portopulmonary hypertension, especially in liver transplant candidates.
Cleve Clin J Med. 2008 Feb;75(2):121-2, 125-30, 133 passim. doi: 10.3949/ccjm.75.2.121.
3
Pulmonary arterial coil embolization for the management of persistent type I hepatopulmonary syndrome after liver transplantation.
J Vasc Interv Radiol. 2007 Dec;18(12):1576-80. doi: 10.1016/j.jvir.2007.08.008.
4
The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients.
Acta Gastroenterol Belg. 2007 Jan-Mar;70(1):6-10.
5
Left atrial volume: a novel predictor of hepatopulmonary syndrome.
Am J Gastroenterol. 2007 Jul;102(7):1392-6. doi: 10.1111/j.1572-0241.2007.01228.x. Epub 2007 Apr 13.
6
Portopulmonary hypertension.
Clin Chest Med. 2007 Mar;28(1):203-18, ix. doi: 10.1016/j.ccm.2006.11.004.
7
The hepatopulmonary syndrome.
J Hepatol. 2006 Oct;45(4):617-25. doi: 10.1016/j.jhep.2006.07.002. Epub 2006 Jul 25.
8
Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax.
Ann Thorac Surg. 2006 Aug;82(2):457-9. doi: 10.1016/j.athoracsur.2006.03.057.
9
Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient.
Scand J Gastroenterol. 2006 Jul;41(7):862-5. doi: 10.1080/00365520500527441.
10
Hepatopulmonary syndrome and right ventricular diastolic functions: an echocardiographic examination.
Echocardiography. 2006 Apr;23(4):271-8. doi: 10.1111/j.1540-8175.2006.00210.x.
Zotero 插件